Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia: A Quality Improvement Study.
作者信息
Sheth Samip, Lee Paul, Bajaj Archna, Cuchel Marina, Hajj Jihane, Soffer Daniel E, Webb Gayley, Hossain Erik, Borovskiy Yulia, Risman Marjorie, Myers Kelly D, Wilemon Katherine A, Rader Daniel J, Jacoby Douglas
机构信息
Department of Medicine (S.S., P.L., A.B., M.C., J.H., D.S., G.W., M.R., D.R., D.J.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Data Analytics Center (E.H., Y.B.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
出版信息
Circ Cardiovasc Qual Outcomes. 2021 Jun;14(6):e007641. doi: 10.1161/CIRCOUTCOMES.120.007641. Epub 2021 Jun 10.
Abstract
摘要
相似文献
1
Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia: A Quality Improvement Study.
Circ Cardiovasc Qual Outcomes. 2021 Jun;14(6):e007641. doi: 10.1161/CIRCOUTCOMES.120.007641. Epub 2021 Jun 10.
2
Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data Screening.
J Am Heart Assoc. 2023 Jul 4;12(13):e030073. doi: 10.1161/JAHA.123.030073. Epub 2023 Jun 29.
3
Examining barriers to cascade screening for familial hypercholesterolemia in the United States.
J Clin Lipidol. 2016 Mar-Apr;10(2):225-7. doi: 10.1016/j.jacl.2015.12.019. Epub 2015 Dec 23.
4
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning.
Eur J Prev Cardiol. 2020 Oct;27(15):1639-1646. doi: 10.1177/2047487319898951. Epub 2020 Feb 4.
5
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
Am Heart J. 2014 Mar;167(3):342-349.e17. doi: 10.1016/j.ahj.2013.12.008. Epub 2013 Dec 21.
6
Results and Lessons of a Pilot Study of Cascade Screening for Familial Hypercholesterolemia in US Primary Care Practices.
J Gen Intern Med. 2020 Jan;35(1):351-353. doi: 10.1007/s11606-019-05485-7.
7
Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening.
Curr Opin Lipidol. 2017 Apr;28(2):136-143. doi: 10.1097/MOL.0000000000000388.
8
Genetic identification of familial hypercholesterolemia within a single U.S. health care system.
Science. 2016 Dec 23;354(6319). doi: 10.1126/science.aaf7000.
9
Identifying patients with familial hypercholesterolemia using data mining methods in the Northern Great Plain region of Hungary.
Atherosclerosis. 2018 Oct;277:262-266. doi: 10.1016/j.atherosclerosis.2018.05.039.
10
Hidden Burden of Electronic Health Record-Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care.
J Am Heart Assoc. 2019 Jul 2;8(13):e011822. doi: 10.1161/JAHA.118.011822. Epub 2019 Jun 29.
引用本文的文献
1
Implementation of genetic testing for heritable cardiac conditions: A scoping review.
Genet Med Open. 2025 Jun 30;3:103441. doi: 10.1016/j.gimo.2025.103441. eCollection 2025.
2
A novel outreach approach for identification of familial hypercholesterolemia: Interview-based formative evaluation to improve healthcare access and quality.
PEC Innov. 2025 Jun 2;6:100407. doi: 10.1016/j.pecinn.2025.100407. eCollection 2025 Jun.
3
Artificial Intelligence Models to Identify Patients at High Risk for Glaucoma Using Self-reported Health Data in a United States National Cohort.
Ophthalmol Sci. 2024 Dec 17;5(3):100685. doi: 10.1016/j.xops.2024.100685. eCollection 2025 May-Jun.
4
Artificial Intelligence Models to Identify Patients with High Probability of Glaucoma Using Electronic Health Records.
Ophthalmol Sci. 2024 Dec 6;5(3):100671. doi: 10.1016/j.xops.2024.100671. eCollection 2025 May-Jun.
5
Beyond identification of familial hypercholesterolemia: Improving downstream visits and treatments in a large health care system: Improving FH Care.
Am J Prev Cardiol. 2025 Jan 24;21:100937. doi: 10.1016/j.ajpc.2025.100937. eCollection 2025 Mar.
6
A Scoping Review of Electronic Health Records-Based Screening Algorithms for Familial Hypercholesterolemia.
JACC Adv. 2024 Oct 16;3(12):101297. doi: 10.1016/j.jacadv.2024.101297. eCollection 2024 Dec.
7
A qualitative study of perceptions of the care pathway for familial hypercholesterolemia: screening, diagnosis, treatment, and family cascade screening.
Implement Sci Commun. 2024 Dec 2;5(1):135. doi: 10.1186/s43058-024-00670-0.
8
Implications of Diagnosis Through a Machine Learning Algorithm on Management of People With Familial Hypercholesterolemia.
JACC Adv. 2024 Aug 21;3(9):101184. doi: 10.1016/j.jacadv.2024.101184. eCollection 2024 Sep.
9
Applications of machine learning in familial hypercholesterolemia.
Front Cardiovasc Med. 2023 Sep 26;10:1237258. doi: 10.3389/fcvm.2023.1237258. eCollection 2023.
10
Genetic Testing for Familial Hypercholesterolemia in Clinical Practice.
Curr Atheroscler Rep. 2023 May;25(5):197-208. doi: 10.1007/s11883-023-01094-2. Epub 2023 Apr 15.
本文引用的文献
1
Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data.
Lancet Digit Health. 2019 Dec;1(8):e393-e402. doi: 10.1016/S2589-7500(19)30150-5. Epub 2019 Oct 21.
2
Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia.
J Am Heart Assoc. 2019 Dec 17;8(24):e013225. doi: 10.1161/JAHA.119.013225. Epub 2019 Dec 16.
3
Genetic identification of familial hypercholesterolemia within a single U.S. health care system.
Science. 2016 Dec 23;354(6319). doi: 10.1126/science.aaf7000.
4
Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.
J Clin Lipidol. 2016 Sep-Oct;10(5):1230-9. doi: 10.1016/j.jacl.2016.08.001. Epub 2016 Aug 6.
5
The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association.
Circulation. 2015 Dec 1;132(22):2167-92. doi: 10.1161/CIR.0000000000000297. Epub 2015 Oct 28.
Zotero 插件